Gain Therapeutics Inc

Research Gain Therapeutics Inc (GANX) on Bullrun: market cap USD 84.45M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGANX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 84.45M
• Financial periodFY2025
• Net income-USD 20.16M

Valuation Snapshot

latest market cap is USD 84.45M.

About Gain Therapeutics Inc

Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia. The company's drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease.

Frequently asked questions

What is Gain Therapeutics Inc's market cap?

Gain Therapeutics Inc's market capitalization is USD 84.45M.

What does Gain Therapeutics Inc do?

Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.